SCHEMBL8874783

SCHEMBL8874783

CCCCCCCCOC(=O)CNC(=O)c1ncc(C(=O)NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)cc2)cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 2/20 0.41
TSHR P16473 2/20 0.41
ABCC3 O15438 1/20 0.41
ABCC4 O15439 1/20 0.41
ABCC9 O60706 1/20 0.41
ABCB11 O95342 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CFTR P13569 1/20 0.41
HTR2A P28223 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8874675 0.92 L3MBTL1 (0.43) KMT2AMEN1CA12CA1CA9
SCHEMBL8104049 0.90 LMNA (0.39) KMT2AMEN1CA12CA1CA9
SCHEMBL8916898 0.87 L3MBTL1 (0.52) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL8874939 0.87 LMNA (0.44) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL8875058 0.86 MEN1 (0.45) KMT2AMEN1
SCHEMBL8875238 0.84 MEN1 (0.44) KMT2AMEN1CYP1A2BLMCNR2
SCHEMBL8873747 0.83 LMNA (0.44) KMT2ACA12CA1CA9LMNA
SCHEMBL8875248 0.83 LMNA (0.41) KMT2ACA12CA1CA9LMNA
SCHEMBL8097851 0.82 LMNA (0.51) KMT2AMEN1L3MBTL1LMNAALDH1A1
SCHEMBL8868031 0.82 LMNA (0.47) KMT2ACA12CA1CA9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5620996-A Sulfonamidocarbonyl pyridine-2-carboxesteramides and their pyridine-N-oxide compounds and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-04-15 US disclosed